NCT03902418View on ClinicalTrials.gov

Evaluation of Pre-Exposure Prophylaxis (PrEP) in Pregnant and Breastfeeding Women

CompletedOBSERVATIONAL
Enrollment

1,195

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

June 30, 2024

Study Completion Date

September 30, 2024

Conditions
HIV-I Infection
Interventions
DRUG

emtricitabine/tenofovir

Women recruited at ante-natal clinics, counseled about PrEP, and provided medication and follow up if desired

Trial Locations (1)

Unknown

University of Cape Town, Cape Town

All Listed Sponsors
collaborator

University of Cape Town

OTHER

lead

University of California, Los Angeles

OTHER

NCT03902418 - Evaluation of Pre-Exposure Prophylaxis (PrEP) in Pregnant and Breastfeeding Women | Biotech Hunter | Biotech Hunter